Matinas BioPharma Holdings, Inc.
MTNB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582554
No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Matinas BioPharma Holdings, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 42 | 48 | +6 |
| Shares | 25.5M | 38.9M | +13.4M (+52.7%) |
| Value | $6.91M | $6.15M | −$755.8K (−10.9%) |
New holders (9)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Highbridge Capital Management LLC | 10,644,331 | $1.68M | 0.07% |
| Alliance Wealth Management Group | 1,886,715 | $298.7K | 0.09% |
| Towercrest Capital Management | 1,886,715 | $298.7K | 0.05% |
| Platform Technology Partners | 156,250 | $24.7K | 0.01% |
| Jane Street Group, LLC | 103,399 | $16.1K | 0.00% |
| Virtu Financial LLC | 40,873 | $6.00K | 0.00% |
| Baader Bank INC | 15,912 | $2.05K | 0.00% |
| Sanctuary Advisors, LLC | 10,200 | $1.82K | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 11,000 | $1.74K | 0.00% |
Sold out (3)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Arkadios Wealth Advisors | 1,624,000 | $440.1K |
| UBS Group AG | 44,893 | $12.2K |
| FMR LLC | 5,000 | $1.35K |